Congress orders breakup of vertically integrated health giants—forcing insurers to choose: doctors o

What it does

This bill prohibits large health care companies from simultaneously owning insurance companies or pharmacy benefit managers AND owning medical providers (doctors, hospitals, pharmacies). It also bars drug wholesalers from owning medical providers. Companies in violation have one year to divest one side of their business. The bill empowers the FTC, DOJ, state attorneys general, and private citizens to sue for violations, with penalties including 10% monthly profit escrow, treble damages, and forced divestiture overseen by a court-appointed trustee.

Why we flagged it

The bill's core mechanism is a forced divestiture requirement—companies must choose between owning insurers/PBMs or medical providers, not both. This is a structural antitrust remedy, not a price cap or regulatory tweak. The operative text is plain and direct about what it prohibits and what must be divested.

What the text implies

• Divestiture may fragment integrated delivery networks, potentially raising administrative costs for smaller divested entities and reducing their negotiating power with remaining large players—a short-term cost to some providers before market rebalancing.
• The 1-year divestiture deadline is aggressive; companies may be forced to sell assets at fire-sale prices, potentially benefiting private equity acquirers and reducing the divested entity's value to employees and communities.

The full analysis lists 5 implications of this text.

Who stands to gain

independent physicians and physician practices (reduced competition from integrated platforms); independent pharmacies (reduced steering by vertically integrated PBMs); private equity firms (potential acquirers of divested assets)